These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 11531923)

  • 1. Bone metabolism and body composition in Japanese patients with active acromegaly.
    Kaji H; Sugimoto T; Nakaoka D; Okimura Y; Kaji H; Abe H; Chihara K
    Clin Endocrinol (Oxf); 2001 Aug; 55(2):175-81. PubMed ID: 11531923
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Determinants of bone mineral density and spinal fracture risk in postmenopausal Japanese women.
    Nakaoka D; Sugimoto T; Kaji H; Kanzawa M; Yano S; Yamauchi M; Sugishita T; Chihara K
    Osteoporos Int; 2001; 12(7):548-54. PubMed ID: 11527051
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Skeletal involvement in female acromegalic subjects: the effects of growth hormone excess in amenorrheal and menstruating patients.
    Scillitani A; Chiodini I; Carnevale V; Giannatempo GM; Frusciante V; Villella M; Pileri M; Guglielmi G; Di Giorgio A; Modoni S; Fusilli S; Di Cerbo A; Liuzzi A
    J Bone Miner Res; 1997 Oct; 12(10):1729-36. PubMed ID: 9333135
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bone mineral, histomorphometry, and body composition in adults with growth hormone receptor deficiency.
    Bachrach LK; Marcus R; Ott SM; Rosenbloom AL; Vasconez O; Martinez V; Martinez AL; Rosenfeld RG; Guevara-Aguirre J
    J Bone Miner Res; 1998 Mar; 13(3):415-21. PubMed ID: 9525342
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gonadal status is an important determinant of bone density in acromegaly.
    Lesse GP; Fraser WD; Farquharson R; Hipkin L; Vora JP
    Clin Endocrinol (Oxf); 1998 Jan; 48(1):59-65. PubMed ID: 9509069
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term maintenance of the anabolic effects of GH on the skeleton in successfully treated patients with acromegaly.
    Biermasz NR; Hamdy NA; Pereira AM; Romijn JA; Roelfsema F
    Eur J Endocrinol; 2005 Jan; 152(1):53-60. PubMed ID: 15762187
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A link between bone mineral density and serum adiponectin and visfatin levels in acromegaly.
    Sucunza N; Barahona MJ; Resmini E; Fernández-Real JM; Ricart W; Farrerons J; Rodríguez Espinosa J; Marin AM; Puig T; Webb SM
    J Clin Endocrinol Metab; 2009 Oct; 94(10):3889-96. PubMed ID: 19723758
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bone mineral density and parameters of bone metabolism in patients with acromegaly.
    Kotzmann H; Bernecker P; Hübsch P; Pietschmann P; Woloszczuk W; Svoboda T; Geyer G; Luger A
    J Bone Miner Res; 1993 Apr; 8(4):459-65. PubMed ID: 8475795
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bone mineral content and bone metabolism during physiological GH treatment in GH-deficient adults--an 18-month randomised, placebo-controlled, double blinded trial.
    Sneppen SB; Hoeck HC; Kollerup G; Sørensen OH; Laurberg P; Feldt-Rasmussen U
    Eur J Endocrinol; 2002 Feb; 146(2):187-95. PubMed ID: 11834427
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum levels of insulin-like growth factor system components and relationship to bone metabolism in Type 1 and Type 2 diabetes mellitus patients.
    Jehle PM; Jehle DR; Mohan S; Böhm BO
    J Endocrinol; 1998 Nov; 159(2):297-306. PubMed ID: 9795371
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of GH-IGF-I excess and gonadal status on bone mineral density and body composition in patients with acromegaly.
    Madeira M; Neto LV; de Lima GA; Moreira RO; de Mendonça LM; Gadelha MR; Farias ML
    Osteoporos Int; 2010 Dec; 21(12):2019-25. PubMed ID: 20306022
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum levels of insulin-like growth factor (IGF); IGF-binding proteins-3, -4, and -5; and their relationships to bone mineral density and the risk of vertebral fractures in postmenopausal women.
    Yamaguchi T; Kanatani M; Yamauchi M; Kaji H; Sugishita T; Baylink DJ; Mohan S; Chihara K; Sugimoto T
    Calcif Tissue Int; 2006 Jan; 78(1):18-24. PubMed ID: 16397738
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In acromegaly, increased bone mineral density (BMD) is determined by GH-excess, gonadal function and gender.
    Zgliczynski W; Kochman M; Misiorowski W; Zdunowski P
    Neuro Endocrinol Lett; 2007 Oct; 28(5):621-8. PubMed ID: 17984937
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bone mineral density in acromegaly: the effect of gender, disease activity and gonadal status.
    Scillitani A; Battista C; Chiodini I; Carnevale V; Fusilli S; Ciccarelli E; Terzolo M; Oppizzi G; Arosio M; Gasperi M; Arnaldi G; Colao A; Baldelli R; Ghiggi MR; Gaia D; Di Somma C; Trischitta V; Liuzzi A
    Clin Endocrinol (Oxf); 2003 Jun; 58(6):725-31. PubMed ID: 12780749
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of low-dose of recombinant human growth hormone on bone metabolism in elderly women with osteoporosis.
    Sugimoto T; Kaji H; Nakaoka D; Yamauchi M; Yano S; Sugishita T; Baylink DJ; Mohan S; Chihara K
    Eur J Endocrinol; 2002 Sep; 147(3):339-48. PubMed ID: 12213671
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Osteopenia occurs in a minority of patients with acromegaly and is predominant in the spine.
    Kayath MJ; Vieira JG
    Osteoporos Int; 1997; 7(3):226-30. PubMed ID: 9205635
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bone mineral density of the axial skeleton in acromegaly.
    Ho PJ; Fig LM; Barkan AL; Shapiro B
    J Nucl Med; 1992 Sep; 33(9):1608-12. PubMed ID: 1517833
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum levels of insulin-like growth factor (IGF) I, IGF-binding protein (IGFBP)-2, and IGFBP-3 in osteoporotic patients with and without spinal fractures.
    Sugimoto T; Nishiyama K; Kuribayashi F; Chihara K
    J Bone Miner Res; 1997 Aug; 12(8):1272-9. PubMed ID: 9258758
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quantitative ultrasound of the heel and some parameters of bone turnover in patients with acromegaly.
    Bolanowski M; Jedrzejuk D; Milewicz A; Arkowska A
    Osteoporos Int; 2002; 13(4):303-8. PubMed ID: 12030545
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of 12 months of recombinant growth hormone therapy on parameters of bone metabolism and bone mineral density in patients on chronic hemodialysis.
    Kotzmann H; Riedl M; Pietschmann P; Schmidt A; Schuster E; Kreuzer S; Kainberger F; Frisch H; Geyer G; Hörl WH; Mayer G; Luger A
    J Nephrol; 2004; 17(1):87-94. PubMed ID: 15151263
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.